Metraipolis › archive › dc_ab537053fc7a

LASSBio-1986 as a Multifunctional Antidiabetic Lead: SGLT1/2 Docking, Redox-Inflammatory Modulation and Metabolic Benefits in C57BL/6 Mice — Europe PMC PMID:41596477

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41596477
DOI
10.3390/ijms27020829
License (as archived)
solo-consultazione
Archived
2026-11-06T19:24:07.827Z
SHA-256 of the archived text
758008ee73989faf661b02896a89e8b1a0e87af98a80cde0a89d0df3a61c473f
Stable URL of this page
https://metraipolis.com/documento/dc_ab537053fc7a

How to cite

LASSBio-1986 as a Multifunctional Antidiabetic Lead: SGLT1/2 Docking, Redox-Inflammatory Modulation and Metabolic Benefits in C57BL/6 Mice — Europe PMC PMID:41596477 — Europe PMC (en), https://europepmc.org/article/MED/41596477 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ab537053fc7a (Metraipolis archive dc_ab537053fc7a, sha256 758008ee73989faf661b02896a89e8b1a0e87af98a80cde0a89d0df3a61c473f)
BibTeX
@misc{dcab537053fc7a,
  title = {LASSBio-1986 as a Multifunctional Antidiabetic Lead: SGLT1/2 Docking, Redox-Inflammatory Modulation and Metabolic Benefits in C57BL/6 Mice — Europe PMC PMID:41596477},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41596477},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ab537053fc7a; sha256 758008ee73989faf661b02896a89e8b1a0e87af98a80cde0a89d0df3a61c473f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41596477. Agents can read the archived copy with the MCP tool read_document.